July 30, 2004
Re "Bush Proposes Cuts in Medicare Payments," July 28: It appears that cancer patients will be losing some prescription medicines and will be forced to go to hospitals instead of receiving treatment in their doctors' offices, "forcing a dramatic change in care," according to the article. (Of course, the government savings of $530 million next year is much more important than saving the lives of cancer patients.) So with this proposal potentially affecting the quality of life of so many people, why did The Times bury it on Page 19 instead of displaying it prominently on the first page?
September 13, 2012 |
The war on cancer is poised to enter a new phase that promises more precise treatments, fewer side effects and, most of all, more survivors. And none too soon. Although death rates from many cancers have slowly but steadily declined over the decades, experts agree that current treatments are mostly too blunt, too scattershot and too dangerous for the patients they are intended to save. Today, treating cancer often means an all-out chemical assault on tumors. Doctors bombard patients' bodies with drugs that aim to destroy cancer cells.
April 18, 2011 |
Cancer cells are riddled with genetic errors, and each tumor has its own unique set of mistakes. Reading those errors, scientists believe, will help them not only understand how a tumor came to be, but also how best to poison it. "Every tumor is telling its own story, its own history," says Kevin White, director of the Institute for Genomics and Systems Biology at the University of Chicago. One by one, he's reading and analyzing those stories as part of the university's $5-million Chicago Cancer Genome Project.
CALIFORNIA | LOCAL
January 5, 2013 |
Elwood Jensen, a medical researcher whose ground-breaking work in the field of endocrinology and breast cancer led to revolutionary and life-saving treatments, died of complications from pneumonia on Dec. 16 in suburban Cincinnati, the University of Cincinnati announced. He was 92. He was repeatedly nominated for the Nobel Prize for his discovery of hormone receptors while at the University of Chicago in the 1950s and 1960s. At Chicago, Jensen focused on the impact that breast tissue had on estrogen while most other researchers analyzed how the hormone influenced tissue.
February 17, 1999 |
Endocare Inc. in Irvine and Cryomedical Sciences Inc. prostate cancer treatments won government approval for coverage by the Medicare health insurance program for the elderly, the Clinton administration said. Medicare now will cover devices and procedures used to freeze tissue to destroy cancer cells, a technique known as cryosurgery, the government announced Friday night.
January 5, 1995 |
A court order requiring a 15-year-old Hmong girl with ovarian cancer to undergo chemotherapy has been lifted by authorities hoping to persuade the girl to return home. Lee Lor, a small 10th-grader, ran away from home in late October after the Juvenile Court here--over the strong protests of her parents and Hmong community leaders--ordered the cancer treatments. "We asked the court to remove the order because it was proving to be a major stumbling block," said Dr.